Evidence map›Paper›PMID 36911735›Full record

ReviewFrontiers in immunology2023

Understanding fibroblast-immune cell interactions

F Thiam, S Al Yazeedi, K Feng, S Phogat, E Demirsoy, J Brussow, F A Abokor, E T Osei

Open access · goldAbstract readReview
In one paragraph

Review in Frontiers in immunology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
7.5field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 29 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Dressed in Collagen: 2D and 3D Cardiac Fibrosis Models.International journal of molecular sciences · 2025
    Review
  9. Article
  10. Review
  11. Review
  12. Review
  13. Review
  14. Article
  15. Article
  16. Review
  17. Review
  18. Review
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

F ThiamDepartment of Biology, University of British Columbia, Kelowna, BC, Canada.
S Al YazeediDepartment of Biology, University of British Columbia, Kelowna, BC, Canada.
K FengDepartment of Biology, University of British Columbia, Kelowna, BC, Canada.
S PhogatDepartment of Biology, University of British Columbia, Kelowna, BC, Canada.
E DemirsoyDepartment of Biology, University of British Columbia, Kelowna, BC, Canada.
J BrussowDepartment of Biology, University of British Columbia, Kelowna, BC, Canada.
F A AbokorDepartment of Biology, University of British Columbia, Kelowna, BC, Canada.
E T OseiDepartment of Biology, University of British Columbia, Kelowna, BC, Canada.
University of British Columbia · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Asthma is a chronic lung disease involving airway inflammation and fibrosis. Fibroblasts are the main effector cells important for lung tissue production which becomes abnormal in asthmatics and is one of the main contributors to airway fibrosis. Although fibroblasts were traditionally viewed solely as structural cells, they have been discovered to be highly active, and involved in lung inflammatory and fibrotic processes in asthma. In line with this, using 2D and 3D

Indexed as

AsthmaCell CommunicationCoculture TechniquesFibroblastsFibrosisHumansInflammationLungairway fibrosisairway inflammationasthmain vitro co-culture modelslung fibroblastlung immune cells

Identifiers

PMID36911735
PMCPMC9996007
OpenAlexW4321596105

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.